The molecular mechanism involved in the development of nasopharyngeal carcinoma

Progress in Biochemistry and Biophysics

Volumn 33, Issue 10, 2006, Pages 922-931

  Li, Gui Yuan ^a   Liu, Hua Ying ^a   Zhou, Ming ^a   Zhou, Hou De ^a   Li, Xiao Ling ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Mechanism of etiology and pathogenesis; Multi step Domino effect; Nasopharyngeal carcinoma; Susceptibility gene group

Indexed keywords

EID: 33846295931     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Verein A V. Meeting of the Society of Physicvans in Hamburg. Germany. The Society of Physicians of Hamburg, Hamburg, 1896
2. Jackson C. Primary carcinoma of the nasopharynx: a table of cases. Journal of the Anerican Medical Association, 1901, 31: 371-377
3. Wei W I, Sham J S. Nasopharyngeal carcinoma. Lancet, 2005, 365 (9476): 2041-2054
4. Chan A T, Teo P M, Johnson P J. Nasopharyngeal carcinoma. Ann Oncol, 2002, 13 (7): 1007-1015
5. Yu M C, Yuan J M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 2002, 12 (6): 421-429
6. Lo K W, To K F, Huang D P. Focus on nasopharyngeal carcinoma. Cancer Cell, 2004, 5 (5): 423-428
7. Manavis J, Sivridis L, Koukourakis MI. Nasopharyngeal carcinoma: The impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease. J Clin Imag, 2005, 29 (2): 128-133
8. Faivre S, Janot F, Armand J P. Optimal management of nasopharyngeal carcinoma. Curr Opin Oncol, 2004, 16(3): 231-235
9. Ma B B, Chan A T. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer, 2005, 103 (1): 22-31
10. Thompson M P, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res, 2004, 10 (3): 803-821
11. O'Meara W P, Lee N. Advances in nasopharyngeal carcinoma. Curr Opin Oncol, 2005, 17 (3): 225-230
12. Li G Y. Foreign Medical Sciences Cancer Section, 1986, (2): 65-70
13. Li G Y. Bulletin of Hunan Medical College, 1987, (1): 15-22
14. Li G Y. Bulletin of Hunan Medical College, 1987, (2): 137-142
15. Li G Y. Bulletin of Hunan Medical University, 1989, (4): 307-311
16. Xiong W, Zeng Z Y, Xia J H, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res, 2004, 64 (6): 1972-1974
17. Xiong W, Zeng Z Y, Shen S R, et al. Chin J Med Genet, 2003, 20 (4): 311-314
18. Feng B J, Huang W, Shugart Y Y, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet, 2002, 31 (4): 395-399
19. Hui A B, Lo K W, Leung S F, et al. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer, 1999, 82 (4): 498-503
20. Lo K W, Teo P M, Hui A B, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res, 2000a, 60 (13): 3348-3353
21. Deng L W, Jiang N, Tan G L, et al. A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma. Genes Chromosome Cancer, 1998, 23 (1): 21-25
22. Tan G, Xiao J, Tian Y, et al. Microsatellite analyses of loci at 7q31.3-q36 reveal a minimum of two common regions of deletion in nasopharyngeal carcinoma. Otolaryngol Head Neck Surg, 2002, 126 (3): 296-300
23. Yang J B, Tang X N, Deng L W, et al. Chinese Journal of Oncology, 1999, 21 (6): 419-421
24. Li Z H, Wang L, Zhang X H, et al. Chin J Med Genet, 2001, 18 (5): 338-342
25. Li Z H, Li G Y. Clinical otolaryngology, 2001, 15 (suppl): 70-75
26. Yang J B, Bin L H, Li Z H, et al. Chinese Journal of Cancer, 2000, 19 (1): 6-9
27. Qian J, Zhang X H, Yang J B, et al. Acta Biochim Biophys Sin, 2001, 33 (2): 147-152
28. Xie Y, Bin L, Yang J, et al. Molecular cloning and characterization of NAG-7:a novel gene downregulated in human nasopharyngeal carcinoma. Chin Med J, 2001, 114 (5): 530-534
29. Chan A S C, To K F, Lo K W, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Research, 2000, 60: 5365-5370
30. Lo K W, Teo P M, Hui A B, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res, 2000, 60 (13): 3348-3353
31. Qiu G H, Tan L K, Loh K S, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene, 2004, 23 (27): 4793-806
32. Rupp P A, Fouad G T, Egelston C A, et al. Identification, genomic organization and mRNA expression of CRELD1, the founding member of a unique family of matricellular proteins. Gene, 2002, 293 (1-2): 47-57
33. Yu Y, Zhu S G, Xiang J J, et al. Prog Biochem Biophys, 2001, 28 (4): 568-572
34. Xiong W, Zeng Z Y, Li X L, et al. Acta Biochim Biophys Sin, 2002, 34 (4): 512-515
35. Xiong W, Zeng Z Y, Shen S R, et al. Prog Biochem Biophys, 2002, 29 (5): 766-770
36. Xiong W, Zeng Z Y, Xiao B Y, et al. Prog Biochem Biophys, 2003, 30 (3): 401-405
37. Gene Co.Led. Biology Teaching, 2004, 29: 3-4
38. Lu Q L, Elia G, Lucas S, et al. Bcl2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. IntJ Cancer, 1993, 53 (1): 29-35
39. Lai J P, Tong C L, Hong C, et al. Association between high initial tissue levels of cyclin D1 and recurrence of nasopharyngeal carcinoma. Laryngoscope, 2002, 112 (2): 402-408
40. Porter M J, Field J K, Leung S F, et al. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol, 1993, 114(1): 105-109
41. Qian C N, Guo X, Cao B, et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res, 2002, 62 (2): 589-596
42. Hui AB, Lo K W, Teo P M, et al. Genome-wide detection of oncogene amplifications in nasopharyngeal carcinoma by array-based comparative genomic hybridization. Int J Oncol, 2002, 20 (3): 467-473
43. Fujii M, Yamashita T, Ishiguro R, et al. Significance of epidermal growth factor receptor and tumour associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx, 2002, 29 (2): 175-181
44. Yu Y, Xie Y, Zhang B C, et al. Chinese Journal of Cancer, 2000, 19 (7): 709-712
45. 45 Zhan F H, Jiang N, Cao L, et al. Chin J Med Genet, 1998, 15 (6): 341-344
46. Zhang B C, Cao L, Qian J, et al. Prog Biochem Biophys, 2002, 29 (2): 302-306
47. Zhang B C, Nie X M, Xiao B Y, et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer, 2003, 38 (1): 80-90
48. Nie X M, Zhang BC, Li X L, et al. Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol, 2003, 129 (7): 410-414
49. Yu Y, Zhang B C, Xie Y, et al. Acta Biochim Biophys Sin, 2000, 32 (4): 327-332
50. Yu Y, Zhu S G, Zhang B C, et al. Screening of BRD7 interacting proteins by yeast two-hybrid system. Science China (Series C) 2002, 32(2): 153-158
51. Cong P, Jie Z, Ying L H, et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J Cell Biochem, 2006, 97 (4): 882-892
52. Zhou J, Ma J, Zhang B C, et al. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J Cell Physiol, 2004, 200 (1): 89-98
53. Zhou M, Liu H, Xu X, et al. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression. J Cell Biochem, 2006, 98 (4): 920-930
54. Li J, Tan C, Xiang Q, et al. Proteomic detection of changes in protein synthesis induced by NGX6 transfected in human nasopharyngeal carcinoma cells. J Protein Chem, 2001, 20 (3): 265-271
55. Ma J, Li J, Zhou J, et al. Profiling genes differentially expressed in NGX6 overexpressed nasopharyngeal carcinoma cells by cDNA array. J Cancer Res Clin Oncol, 2002, 128 (12): 683-690
56. Ma J, Zhou J, Fan S, et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis, 2005, 26 (2): 281-291
57. Wang L, Ma J, Li J, et al. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem, 2005, 95 (1): 64-73
58. Tan C, Li J, Xie Y, et al. Preliminary function study of NAG7 using two-dimensional electrophoresis and mass spectrometry. Acta Biochim Biophys Sin, 2001, 33 (4): 373-378.
59. Tan C, Peng C, Huang Y C, et al. Effects of NPC-associated gene NAG7 on cell cycle and apoptosis in nasopharyngeal carcinoma cells. Ai Zheng, 2002, 21 (5): 449-455
60. Tan C, Li J, Wang J, et al. Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection. Proteomics, 2002, 2 (3): 306-312
61. Crook T, Nicholls J M, Brooks L, et al. High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?. Oncogene, 2000, 19 (30): 3439-3444
62. Lu Q L, Elia G, Lucas S, et al. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer, 1993, 53 (1): 29-35
63. Jayasurya A, Bay B H, Yap W M, et al. Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer, 2000, 82 (6): 1198-1203
64. Wang X, Xu K, Ling M T, et al. Evidence of increased Id-1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells. Mol Carcinog, 2002, 35: 42-49
65. Qian J, Zhang X H, Yang J B, et al. Cloning and expression analysis of a novel gene, UBAP1, possibly involved in ubiquitin pathway. Acta Biochim Biophys Sin, 2001, 33 (2): 147-152
66. Qian J, Yang J, Zhang X, et al. Isolation and characterization of a novel cDNA, UBAP1, derived from the tumor suppressor locus in human chromosome 9p21-22. J Cancer Res Clin Oncol, 2001, 127 (10): 613-618
67. Xiao B, Fan S, Zeng Z, et al. Purification of novel UBAP1 protein and its decreased expression on nasopharyngeal carcinoma tissue microarray. Protein Expr Purif, 2006, 47 (1): 60-67
68. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol, 2002, 12 (6): 431-441.
69. Burgos J S. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol, 2005, 22 (2): 113-121
70. Young L S, Rickinson A B. Epstein-Barr virus: 40 years on. Nat Rev Cancer, 2004, 4 (10): 757-768
71. Busson P, Keryer C, Ooka T, et al. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol, 2004, 12 (8): 356-360
72. Zhou H D, Li G Y, Yang Y X, et al. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HKE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol, 2006, 43(11): 1864-1871
73. Zhou H D, Fan S Q, Zhao J, et al. Tissue distribution of the secretory protein, SPLUNC1, in the human fetus. Histochem Cell Biol, 2006, 125 (3): 315-324
74. Zhou H D, Li X L, Li G Y. Prog Biochem Biophys, 2004, 31 (9): 1-5
75. Ghafouri B, Kihlstrom E, Tagesson C, et al. PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta, 2004, 1699 (1-2): 57-63
76. Hancock R E W, Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Current Drug Targets - Infectious Disorders, 2002, 2 (1): 79-83
77. Li G Y. Genetics and Disease, 1986, (2): 76-78
78. Li G Y. Bulletin of Hunan Medical College, 1983, 12 (4): 373-378
79. Nie X M, Zhang B C, Li X L, et al. Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol, 2003, 129 (7): 410-414
80. Nie X M, Xiao B Y, Li X L, et al. Chinese Journal of Cancer, 2003, 22 (2): 136-139
81. Nie X M, Zhou M, Gui R, et al. Expression of nitroreductase gene NOR1 in E. coli and the preparation of antiserum. Chin J Cancer Res, 2004, 16: 11-14
82. Felmer R N, Clark J A. The gene suicide system Ntr/CB1954 causes ablation of differentiated 3T3L1 adipocytes by apoptosis. Biol Res, 2004, 37 (3): 449-460
83. Green N K, Young D J, Neoptolemos J P, et al. Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5(aziridin 1-yl)-2,4′ dinitrobenzamide(CB1954) by retroviral transduction and expression of the E. coli nitroreductase gene. Cancer Gene Ther, 1997, 4 (4): 229-238
84. Bridgewater J A, Knox R J, Pitts J D, et al. The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cellpermeable metabolite. Hum Gene Ther, 1997, 8 (6): 709-717